161 related articles for article (PubMed ID: 33035331)
1. MLL-TFE3: a novel and aggressive KMT2A fusion identified in infant leukemia.
Kosasih HJ; Davidson NM; Bjelosevic S; Morrish E; Brennan MS; Oshlack A; Johnstone RW; Brumatti G; Khaw SL; Ekert PG
Blood Adv; 2020 Oct; 4(19):4918-4923. PubMed ID: 33035331
[TBL] [Abstract][Full Text] [Related]
2. A novel KMT2A-ACTN2 fusion in infant B-cell acute lymphoblastic leukemia.
Yoshida M; Nakabayashi K; Ogata-Kawata H; Osumi T; Tsujimoto SI; Shirai R; Yoshida K; Okamura K; Matsumoto K; Kiyokawa N; Tomizawa D; Hata K; Kato M
Pediatr Blood Cancer; 2019 Aug; 66(8):e27821. PubMed ID: 31115144
[No Abstract] [Full Text] [Related]
3. KMT2A-CBL fusion in rapidly progressive myeloid disorder.
Chaum M; Vail E; Schreck R; Lorber J; Eno CC
Cancer Genet; 2022 Aug; 266-267():90-92. PubMed ID: 35933946
[No Abstract] [Full Text] [Related]
4. Identification of a novel KMT2A/GIMAP8 gene fusion in a pediatric patient with acute undifferentiated leukemia.
Berg HE; Blackburn PR; Baughn LB; Ketterling RP; Xu X; Greipp PT; Hoppman NL; Smadbeck JB; Vasmatzis G; Shi M; Reichard KK; Viswanatha DS; Jevremovic D; Maher GM; Peterson JF
Genes Chromosomes Cancer; 2021 Feb; 60(2):108-111. PubMed ID: 33078871
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of KMT2A fusion partner genes in 13 cases of pediatric leukemia with complex or cryptic karyotypes.
Ney Garcia DR; de Souza MT; de Figueiredo AF; Othman MAK; Rittscher K; Abdelhay E; Capela de Matos RR; Meyer C; Marschalek R; Land MGP; Liehr T; Ribeiro RC; Silva MLM
Hematol Oncol; 2017 Dec; 35(4):760-768. PubMed ID: 27282883
[TBL] [Abstract][Full Text] [Related]
6. Long-term remission of therapy-related acute myeloid leukemia with a new t(11;18)(q23;q21.2) translocation and KMT2A-ME2 (MLL-ME2) fusion gene.
Szotkowski T; Jarošová M; Zimmermannová O; Meyer C; Marschalek R; Zuna J; Hubáček J; Indrák K
Cancer Genet; 2015 Dec; 208(12):610-4. PubMed ID: 26556690
[TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia with t(10;11)(p11-12;q23.3): Results of Russian Pediatric AML registration study.
Zerkalenkova E; Lebedeva S; Kazakova A; Tsaur G; Starichkova Y; Timofeeva N; Soldatkina O; Aprelova E; Popov A; Ponomareva N; Baidun L; Meyer C; Novichkova G; Maschan M; Maschan A; Marschalek R; Olshanskaya Y
Int J Lab Hematol; 2019 Apr; 41(2):287-292. PubMed ID: 30624859
[TBL] [Abstract][Full Text] [Related]
8. Acute leukemias harboring KMT2A/MLLT10 fusion: a 10-year experience from a single genomics laboratory.
Peterson JF; Sukov WR; Pitel BA; Smoley SA; Pearce KE; Meyer RG; Williamson CM; Smadbeck JB; Vasmatzis G; Hoppman NL; Greipp PT; Baughn LB; Ketterling RP
Genes Chromosomes Cancer; 2019 Aug; 58(8):567-577. PubMed ID: 30707474
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal ATP5L-KMT2A gene fusion in a paediatric B lymphoblastic leukaemia/lymphoma (B-ALL) patient.
Gestrich CK; Sadri N; Sinno MG; Pateva I; Meyerson HJ
Br J Haematol; 2020 Oct; 191(2):e61-e64. PubMed ID: 32729113
[No Abstract] [Full Text] [Related]
10. Identification of enhancer of mRNA decapping 4 as a novel fusion partner of
Becker H; Greve G; Kataoka K; Mallm JP; Duque-Afonso J; Ma T; Niemöller C; Pantic M; Duyster J; Cleary ML; Schüler J; Rippe K; Ogawa S; Lübbert M
Blood Adv; 2019 Mar; 3(5):761-765. PubMed ID: 30833276
[TBL] [Abstract][Full Text] [Related]
11. First report of t(5;11) KMT2A-MAML1 fusion in de novo infant acute lymphoblastic leukemia.
Tandon S; Shago M; Davidson S; Kanwar N; Fuligni F; Shlien A; Whitlock J; Villani A; Abla O
Cancer Genet; 2020 Oct; 248-249():31-33. PubMed ID: 32992102
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel KMT2A-SEPT14 fusion in acute myeloid leukemia.
Nguyen D; Haley L; Pallavajjala A; Gojo I; Ning Y
Leuk Lymphoma; 2018 Jan; 59(1):265-267. PubMed ID: 28573893
[No Abstract] [Full Text] [Related]
13. Hematopoietic transformation in the absence of MLL1/KMT2A: distinctions in target gene reactivation.
Chen Y; Ernst P
Cell Cycle; 2019 Jul; 18(14):1525-1531. PubMed ID: 31161857
[TBL] [Abstract][Full Text] [Related]
14. A novel KMT2A-USO1 fusion gene-induced de novo secondary acute myeloid leukaemia in a patient initially diagnosed with acute promyelocytic leukaemia.
Jin W; Chen L; Liu Y; Chen Q; Zhao M; Tan Y; Zhang W; Song H; Weng X; Mi J; Chen S; Chen Z; Li J; Wang K
Br J Haematol; 2021 Jan; 192(1):e32-e36. PubMed ID: 33216970
[No Abstract] [Full Text] [Related]
15. A Novel KMT2A-ARHGEF12 Fusion Gene Identified in a High-Grade B-cell Lymphoma.
Jung HS; Lin F; Wolpaw A; Reilly AF; Margolskee E; Luo M; Wertheim GB; Li MM
Cancer Genet; 2020 Aug; 246-247():41-43. PubMed ID: 32805689
[No Abstract] [Full Text] [Related]
16. Novel MLL/KMT2A-MON2 fusion in a child with therapy-related acute myeloid leukemia after treatment for acute promyelocytic leukemia.
Gong Y; Wang M; Shen H; Chen Y; Cen J; Yin X; Yao L
Mol Carcinog; 2021 Nov; 60(11):721-725. PubMed ID: 34236108
[TBL] [Abstract][Full Text] [Related]
17. A pediatric case of secondary T-cell acute lymphoblastic leukemia with KMT2A-MAML2 developing after hepatoblastoma treatment.
Takahashi Y; Terui K; Chinen Y; Tandai S; Kudo K; Sasaki S; Tono C; Taki T; Ito E
Pediatr Blood Cancer; 2020 Jan; 67(1):e28033. PubMed ID: 31599492
[No Abstract] [Full Text] [Related]
18. KMT2A (MLL) fusions in aggressive sarcomas in young adults.
Yoshida A; Arai Y; Tanzawa Y; Wakai S; Hama N; Kawai A; Shibata T
Histopathology; 2019 Oct; 75(4):508-516. PubMed ID: 31136005
[TBL] [Abstract][Full Text] [Related]
19. Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants.
Fazio G; Bardini M; De Lorenzo P; Grioni A; Quadri M; Pedace L; Corral Abascal L; Palamini S; Palmi C; Buldini B; Vinti L; Parasole R; Barisone E; Zecca M; Favre C; Locatelli F; Conter V; Rizzari C; Valsecchi MG; Biondi A; Cazzaniga G
Blood; 2021 Apr; 137(14):1980-1984. PubMed ID: 33512459
[No Abstract] [Full Text] [Related]
20. Murine Retrovirally-Transduced Bone Marrow Engraftment Models of MLL-Fusion-Driven Acute Myelogenous Leukemias (AML).
Stubbs MC; Krivtsov AV
Curr Protoc Pharmacol; 2017 Sep; 78():14.42.1-14.42.19. PubMed ID: 28892146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
